MPH Mittelstaendische Pharma Holding AG is a German-based company engaged, through its subsidiaries, in the development, production, licensing, and sale of generics in Germany. The Company also involves in the licensing and import of patent protected EU branded pharmaceuticals. Its product line includes pharmaceutical products for oncology, HIV, neurology, rheumatism, cardiovascular, lifestyle medicine, and rheumatology. The Company also provides veterinary pharmaceutical and medical products, as well as animal complement feed. Its veterinary products primarily focus on horse therapy treatment, which comprise products for the musculoskeletal system and immune system.